Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts?

References

• Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K, . The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant. 2009;43: 275–91.
   PubMed Web of Science ®Google Scholar
• Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Loffler H, . G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol. 1994;87:609–13.
   PubMed Web of Science ®Google Scholar
• Council of Europe Publishing. Guide to the Preparation, Use and Quality Assurance of Blood Components. Council of Europe Publishing, Strasbourg Cedex 2007.
   Google Scholar
• Barnett D, Janossy G, Lubenko A, Matutes E, Newland A, Reilly JT. Guideline for the flow cytometric enumeration of CD34+haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin Lab Haematol. 1999;21:301–8.
   PubMedGoogle Scholar
• Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, . The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant. 1996;17: 509–15.
   PubMed Web of Science ®Google Scholar
• Galmes A, Gutierrez A, Sampol A, Canaro M, Morey M, Iglesias J, . Long-term hematological reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10% dimethylsulfoxide at −80 degrees C in a mechanical freezer. Haematologica. 2007;92:986–9.
   PubMedGoogle Scholar
• Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, . Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967–72.
   PubMed Web of Science ®Google Scholar
• Carral A, de la Rubia J, Martín G, Martínez J, Sanz G, Jarque I, . Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Bone Marrow Transplant. 2002;29:825–32.
   PubMed Web of Science ®Google Scholar
• Johnsen HE, Baech J, Nikolajsen K. Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: report from the third workshop, Nordic Stem Cell Laboratory Group. J Hematother. 1999;8:15–28.
   PubMedGoogle Scholar
• Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, . Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. CD34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br J Haematol. 2000;108:784–92.
   PubMed Web of Science ®Google Scholar
• Gratama JW, Kraan J, Keeney M, Sutherland DR, Granger V, Barnett D. Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy. 2003;5:55–65.
   PubMed Web of Science ®Google Scholar
• Pettengell R. Blood stem cell transplantation. Reiffers J, Goldman JM, Armitage JO. Hematopoietic recovery following transplantation (Chapter 6). Martin Dunitz Ltd, London; 1998. 157–70.
   Google Scholar
• Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y, . Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008;30:425–37.
   PubMed Web of Science ®Google Scholar
• Torres A, Sanchez J, Lakomsky D, Serrano J, Alvarez MA, Martin C, . Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation. Haematologica. 2001;86:24–9.
   PubMedGoogle Scholar
• Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD, . The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005;106: 1867–74.
   PubMed Web of Science ®Google Scholar
• Pelus LM. Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand. Curr Opin Hematol. 2008;15:285–92.
   PubMedGoogle Scholar
• Isidori A, Tani M, Bonifazi F, Zinzani P, Curti A, Motta MR, . Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. Haematologica. 2005;90:225–31.
   PubMedGoogle Scholar
• Shpall EJ. The utilization of cytokines in stem cell mobilization strategies. Bone Marrow Transplant. 1999;23:S13–9.
   PubMed Web of Science ®Google Scholar
• Cashen AF, Lazarus HM, Devine SM. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? Bone Marrow Transplant. 2007;39:577–88.
   PubMed Web of Science ®Google Scholar
• Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood. 2001;98:1289–97.
   PubMed Web of Science ®Google Scholar
• Haas R, Ehrhardt R, Witt B, Goldschmidt H, Hohaus S, Pforsich M, . Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma, Bone Marrow Transplant. 1993;12:643–9.
   PubMedGoogle Scholar
• Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, . Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol. 1996;24: 839–47.
   PubMedGoogle Scholar
• Calandra G, McCarty J, McGuirk J, Tricot G, Crocker SA, Badel K, Grove B, . AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant. 2008;41:331–8.
   PubMed Web of Science ®Google Scholar
• D'Addio A, Curti A, Worel N, Douglas K, Motta MR, Rizzi S, . The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. Bone Marrow Transplant. 2011;46(3):356–63.
   PubMedGoogle Scholar
• Holtan SG, Porrata LF, Micallef IN, Padley DJ, Inwards DJ, Ansell SA, . AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma. Clin Lymphoma Myeloma. 2007;7:315–18.
   PubMedGoogle Scholar
• Calandra G, Bridger G, Fricker S. CXCR4 in clinical hematology. Curr Top Microbiol Immunol. 2010;341:173–91.
   PubMed Web of Science ®Google Scholar
• Koenigsmann M, Jentsch-Ullrich K, Mohren M, Becker E, Heim M, Franke A. The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. Transfusion. 2004;44:777–84.
   PubMed Web of Science ®Google Scholar
• Abrahamsen JF, Stamnesfet S, Liseth K, Hervig T, Bruserud O. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion. 2005;45:248–53.
   PubMedGoogle Scholar
• Frey NV, Lazarus HM, Goldstein SC. Has allogeneic stem cell cryopreservation been given the ‘cold shoulder’? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;38:399–405.
   PubMed Web of Science ®Google Scholar
• Kim DH, Jamal N, Saragosa R, Loach D, Wright J, Gupta V, . Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts. Biol Blood Marrow Transplant. 2007;13:1233–43.
   PubMed Web of Science ®Google Scholar
• Rowley SD. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother. 1992;1:233–50.
   PubMedGoogle Scholar
• Rowley SD. Hematopoietic stem cell transplantation between red cell incompatible donor–recipient pairs. Bone Marrow Transplant. 2001;28:315–21.
   PubMedGoogle Scholar
• Gee AP. Blood stem cell transplantation. Reiffers J, Goldman JM, Armitage JO. Collection and processing of peripheral blood hematopoietic progenitor cells (Chapter 4). Martin Dunitz Ltd, London; 1998. 55–72.
   Google Scholar
• Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centers. Bone Marrow Transplant. 2005;36:601–3.
   PubMed Web of Science ®Google Scholar
• Rowley SD, Bensinger WI, Gooley TA, Buckner CD. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood. 1994;83:2731–6.
   PubMed Web of Science ®Google Scholar
• Cabezudo E, Dalmases C, Ruz M, Sanchez JA, Torrico C, Sola C, . Leukapheresis components may be cryopreserved at high cell concentrations without additional loss of HPC function. Transfusion. 2000;40:1223–7.
   PubMedGoogle Scholar
• Szmant HH. Physical properties of dimethyl sulfoxide and its function in biological systems. Ann NY Acad Sci. 1975;243: 20–3.
   PubMed Web of Science ®Google Scholar
• Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, . Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 1998;18:4705–8.
   PubMed Web of Science ®Google Scholar
• Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant. 1990;5:25–7.
   PubMed Web of Science ®Google Scholar
• Alessandrino EP, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, . Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant. 1999;23: 533–7.
   PubMed Web of Science ®Google Scholar
• Nishihara G, Sakemi T, Ikeda Y, Baba N, Shimamoto Y. Multiple organ failure associated with dimethylsulfoxide and hydroxyethyl starch in autologous blood stem cell transplantation. Nephron. 1996;72:356–7.
   PubMed Web of Science ®Google Scholar
• Bauwens D, Hantson P, Laterre PF, Michaux L, Latinne D, Tourtchaninoff MD, . Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma. 2005;46:1671–4.
   PubMed Web of Science ®Google Scholar
• Hentschke S, Hentschke M, Hummel K, Salwender HJ, Braumann D, Stang A. Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cells. Leuk Lymphoma. 2006;47:2418–20.
   PubMed Web of Science ®Google Scholar
• Chen-Plotkin AS, Vossel KA, Samuels MA, Chen MH. Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation. Neurology. 2007;68:859–61.
   PubMedGoogle Scholar
• Saba N, Sutton D, Ross H, Siu S, Crump R, Keating A, . High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant. 1999;24:853–5.
   PubMed Web of Science ®Google Scholar
• Zenhäusern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol. 2000;79:523–6.
   PubMed Web of Science ®Google Scholar
• Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant. 2000;25:1299–301.
   PubMed Web of Science ®Google Scholar
• Willhite CC, Katz PI. Toxicology updates. Dimethyl sulfoxide. J Appl Toxicol. 1984;4:155–60.
   PubMedGoogle Scholar
• Rowley SD, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B, . A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant. 2003;31: 1043–51.
   PubMed Web of Science ®Google Scholar
• Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, . Uncontrolled-rate freezing and storage at −80°C, with only 3.5% DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion. 2001;41:667–73.
   PubMed Web of Science ®Google Scholar
• Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM, . Hepatitis B transmission from contaminated cryopreservation tank. Lancet. 1995;346:137–40.
   PubMed Web of Science ®Google Scholar
• Fountain D, Ralston M, Higgins N, Gorlin JB, Uhl L, Wheeler C, . Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion. 1997;37:585–91.
   PubMed Web of Science ®Google Scholar
• Makino S, Harada M, Akashi K, Taniguchi S, Shibuya T, Inaba S, . A simplified method for cryopreservation of peripheral blood stem cells at −80 degrees C without rate-controlled freezing, Bone Marrow Transplant. 1991;8: 239–44.
   Google Scholar
• Montanari M, Capelli D, Poloni A, Massidda D, Brunori M, Spitaleri L, . Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 degrees C. Transfusion. 2003;43:42–9.
   PubMedGoogle Scholar
• Galmes A, Besalduch J, Bargay J, Novo A, Morey M, Guerra JM, . Long-term storage at −80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion. 1999;39:70–3.
   PubMed Web of Science ®Google Scholar
• Almici C, Ferremi P, Lanfranchi A, Ferrari E, Verardi R, Marini M, . Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors. Haematologica. 2003;88:1390–5.
   PubMedGoogle Scholar
• Rollig C, Babatz J, Wagner I, Maiwald A, Schwarze V, Ehninger G, . Thawing of cryopreserved mobilized peripheral blood: comparison between waterbath and dry warming device. Cytotherapy. 2002;4:551–5.
   PubMed Web of Science ®Google Scholar
• Abrahamsen JF, Rusten L, Bakken AM, Bruserud O. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion. 2004;44:785–9.
   PubMed Web of Science ®Google Scholar
• Curcoy AI, Alcorta I, Estella J, Rives S, Toll T, Tuset E. Cryopreservation of HPCs with high cell concentration in 5-percent DMSO for transplantation to children. Transfusion. 2002;42:962.
   PubMed Web of Science ®Google Scholar
• Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica. 1996;81:59–61.
   PubMed Web of Science ®Google Scholar
• Calmels B, Houze P, Hengesse JC, Ducrot T, Malenfant C, Chabannon C. Preclinical evaluation of an automated closed fluid management device, Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant. 2003;31:823–8.
   PubMed Web of Science ®Google Scholar
• Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant. 2004;10:135–41.
   PubMed Web of Science ®Google Scholar
• Rodriguez L, Velasco B, Garcia J, Martin-Henao GA. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion. 2005;45:1391–7.
   PubMed Web of Science ®Google Scholar
• Lemarie C, Calmels B, Malenfant C, Arneodo V, Blaise D, Viret F, . Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate. Transfusion. 2005;45: 737–42.
   PubMedGoogle Scholar
• Fois E, Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D, . Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant. 2007;40:831–5.
   PubMed Web of Science ®Google Scholar
• Akkok CA, Holte MR, Tangen JM, Ostenstad B, Bruserud. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells. Transfusion. 2009;49:354–61.
   PubMed Web of Science ®Google Scholar
• Nagamura-Inoue T, Shioya M, Sugo M, Cui Y, Takahashi A, Tomita S, . Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion. 2003;43:1285–95.
   PubMed Web of Science ®Google Scholar
• Perotti CG, Del FC, Viarengo G, Papa P, Rocchi L, Bergamaschi P, . A new automated cell washer device for thawed cord blood units. Transfusion. 2004;44:900–6.
   PubMedGoogle Scholar
• Galmes A, Besalduch J, Bargay J, Matamoros N, Duran MA, Morey M, . Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at −80 degrees C without rate-controlled freezing. Transfusion. 1996;36:794–7.
   PubMedGoogle Scholar
• Akkök CA, Liseth K, Nesthus I, Løkeland T, Tefre K, Bruserud O, Abrahamsen JF. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation. Transfusion. 2008;48:877–83.
   PubMed Web of Science ®Google Scholar
• Liseth K, Ersvær E, Abrahamsen JF, Nesthus I, Ryningen A, Bruserud O. Long-term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells. Transfusion. 2009;49(8):1709–19.
   PubMedGoogle Scholar
• Akkök CA, Liseth K, Hervig T, Ryningen A, Bruserud Ø, Ersvaer E. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators. Cytotherapy. 2009;11: 749–60.
   PubMed Web of Science ®Google Scholar
• Stroncek DF, Clay ME, Smith J, Herr G, Ilstrup S, Kunkel LA, . Composition of peripheral blood progenitor cell components collected from healthy donors. Transfusion. 1997;37: 411–7.
   PubMed Web of Science ®Google Scholar
• Stroncek DF, Clay ME, Jaszcz W, Lennon S, Smith J, McCullough J. Collection of two peripheral blood stem cell concentrates from healthy donors. Transfus Med. 1999;9: 37–50.
   PubMed Web of Science ®Google Scholar
• Bruserud O, Foss B, Abrahamsen JF, Gjertsen BT, Ernst P. Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse? J Hematother Stem Cell Res. 2000;9:433–43.
   PubMedGoogle Scholar
• Foss B, Abrahamsen JF, Bruserud O. Peripheral blood progenitor cell grafts contain high levels of platelet-secreted mediators. Transfusion. 2001;41:1431–7.
   PubMed Web of Science ®Google Scholar
• Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion. 2006;46:800–10.
   PubMed Web of Science ®Google Scholar
• Saigo K, Kumagai S, Sugimoto T, Matsui T, Ryo R. RANTES and p-selectin in peripheral blood stem cell harvest. Ther Apher. 2001;5:517–8.
   PubMedGoogle Scholar
• Foss B, Bruserud O, Hervig T. Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro. Platelets. 2008;19:155–9.
   PubMed Web of Science ®Google Scholar
• Nomura S, Inami N, Kanazawa S, Iwasaka T, Fukuhara S. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells. 2004;22:696–703.
   PubMedGoogle Scholar
• Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner AR, . Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood. 2001;98:3143–9.
   PubMed Web of Science ®Google Scholar
• Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med. 2001;11:403–17.
   PubMed Web of Science ®Google Scholar
• Cordoba R, Arrieta R, Kerguelen A, Hernandez-Navarro F. The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product. Bone Marrow Transplant. 2007;40:1063–7.
   PubMed Web of Science ®Google Scholar
• Gutensohn K, Maerz M, Kuehnl P. Alteration of platelet-associated membrane glycoproteins during extracorporeal apheresis of peripheral blood progenitor cells. J Hematother. 1997;6:315–21.
   PubMedGoogle Scholar
• Bruserud O, Foss B, Ulvestad E, Hervig T. Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor. Platelets. 1998; 9:352–8.
   PubMed Web of Science ®Google Scholar
• Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol. 2007;81: 15–27.
   PubMed Web of Science ®Google Scholar
• Jacobsen E, Freedman A. B-cell purging in autologous stem-cell transplantation for non-Hodgkin lymphoma. Lancet Oncol. 2004;5:711–7.
   PubMed Web of Science ®Google Scholar
• Gee A. Purging of peripheral blood stem cell grafts. Stem Cells. 1995;13:52–62.
   PubMedGoogle Scholar
• Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroxycyclophosphamide-purged bone marrow and the busulfan/etiposide preparative regimen: a follow-up report. Bone Marrow Transplant. 1998;22:865–72.
   PubMed Web of Science ®Google Scholar
• Atta J, Fauth F, Keyser M, Petershofen E, Weber C, Lippok G, . Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction. Bone Marrow Transplant. 2000;25: 97–104.
   PubMed Web of Science ®Google Scholar
• van Heeckeren WJ, Vollweiler J, Fu P, Cooper BW, Meyerson H, Lazarus HM, . Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device. Br J Haematol. 2006;132:42–55.
   PubMedGoogle Scholar
• Lemoli RM, Martinelli G, Zamagni E, Motta MR, Rizzi S, Terragna C, . Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy Blood. 2000;95:2234–9.
   Google Scholar
• Negrin RS, Kusnierz-Glaz CR, Still BJ, Schriber JR, Chao NJ, Long GD, . Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood. 1995;85:3334–41.
   PubMed Web of Science ®Google Scholar
• Voso MT, Hohaus S, Moos M, Haas R. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma. Blood. 1997;89:3763–8.
   PubMed Web of Science ®Google Scholar
• Bourhis JH, Bouko Y, Koscielny S, Bakkus M, Greinix H, Derigs G, . European Group for Blood and Marrow Transplantation. Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. Haematologica. 2007;92:1083–90.
   PubMedGoogle Scholar
• Vescio R, Schiller G, Stewart AK, Ballester O, Noga S, Rugo H, . Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood. 1999;15:1858–68.
   Google Scholar
• Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, . Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma, Blood. 2001;98:579–85.
   Google Scholar
• Kumar S, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, . Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant. 2001;28:951–6.
   PubMed Web of Science ®Google Scholar
• Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood. 2001;98: 3192–204.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Thompson JS, Carter SL, Kernan KA. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial. Lancet. 2005;366:733–41.
   PubMed Web of Science ®Google Scholar
• Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, . Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group. Blood. 2000;95: 7–11.
   PubMed Web of Science ®Google Scholar
• de Greef GE, van Putten WL, Boogaerts M, Huijgens PC, Verdonck LF, Vellenga E, . Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies. Br J Haematol. 2005;128:184–91.
   PubMed Web of Science ®Google Scholar